NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence

Psychopharmacology

Volumn 232, Issue 7, 2015, Pages 1177-1186

  Bidwell, L C ^a,b,c   McGeary, J E ^a,b,c,d   Gray, J C ^e   Palmer, R H C ^b,c   Knopik, V S ^b,c   MacKillop, J ^f  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Department of Psychology University of Georgia ^*  (United States)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Dopamine; Endophenotype; Haplotype; Nicotine; SNP

Indexed keywords

DNA; DOPAMINE 2 RECEPTOR; NERVE CELL ADHESION MOLECULE; TETRATRICOPEPTIDE REPEAT PROTEIN; ANKK1 PROTEIN, HUMAN; CD56 ANTIGEN; DRD2 PROTEIN, HUMAN; NCAM1 PROTEIN, HUMAN; PROTEIN; PROTEIN SERINE THREONINE KINASE; TTC12 PROTEIN, HUMAN;

ADULT; ANKK1 GENE; ARTICLE; AUTOMATISM; BEHAVIOR ASSESSMENT; BEHAVIOR CONTROL; CHROMOSOME 11Q; DNA DETERMINATION; DRD2 GENE; FEMALE; GENE; GENE CLUSTER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NCAM1 GENE; PHENOTYPE; PRIMARY DEPENDENCE MOTIVES; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO DEPENDENCE; TTC12 GENE; WISCONSIN INVENTORY OF SMOKING MOTIVES; WITHDRAWAL SYNDROME; ADOLESCENT; CAUCASIAN; GENETIC VARIATION; GENETICS; TOBACCO USE DISORDER; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD56; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HUMANS; MALE; MOTIVATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTORS, DOPAMINE D2; SMOKING; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84925516245     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3748-2     Document Type: Article

References (48)

1. (NCI) NCI (2009) Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. National Cancer Institute Tobacco Control Monograph Series No. 20, Bethesda, p 654
2. Baker TB, Weiss RB, Bolt D, von Niederhausern A, Fiore MC, Dunn DM, Piper ME, Matsunami N, Smith SS, Coon H, McMahon WM, Scholand MB, Singh N, Hoidal JR, Kim SY, Leppert MF, Cannon DS (2009) Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res 11:785-796
3. Barrett JC (2009) Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009: pdb ip71
4. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
5. Benjamini Y, Hochberg Y (1995) Multiple testing. J R Stat Soc Ser B Methodol 57:289-300
6. Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295-2303
7. Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, Tildesley E, Hops H, Tyndale RF, Benowitz NL, Lerman C, Swan GE (2009) Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology 34:2252-2264
8. Ducci F, Kaakinen M, Pouta A, Hartikainen AL, Veijola J, Isohanni M, Charoen P, Coin L, Hoggart C, Ekelund J, Peltonen L, Freimer N, Elliott P, Schumann G, Jarvelin MR (2011) TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol Psychiatry 69:650-660
9. Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481-1489
10. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
11. Gauderman WJ (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155:478-484
12. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L (2006) Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 15:3498-3507
13. Gelernter J, Panhuysen C, Weiss R, Brady K, Poling J, Krauthammer M, Farrer L, Kranzler HR (2007) Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus. Biol Psychiatry 61:119-126
14. Goldman D, Ducci F (2007) Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. ScientificWorldJournal 7:124-130
15. Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6:521-532
16. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645
17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119-1127
18. IBM (2010) IBM SPSS statistics for windows, version 19.0. IBM Corp, Armonk
19. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC (1999) Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290-296
20. Laucht M, Becker K, Frank J, Schmidt MH, Esser G, Treutlein J, Skowronek MH, Schumann G (2008) Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. J Am Acad Child Adolesc Psychiatry 47:673-681
21. Li MD, Ma JZ, Beuten J (2004) Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66:382-392
22. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE (2006) Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women∈<∈or∈=∈55 years. Carcinogenesis 27:2209-2216
23. MacKillop J, Munafò M (2013) Genetic influences on addiction: an intermediate phenotype approach. MIT Press, Cambridge
24. MacKillop J, Obasi E, Amlung MT, McGeary JE, Knopik VS (2010) The role of genetics in nicotine dependence: mapping the pathways from genome to syndrome. Curr Cardiovasc Risk Rep 4:446-453
25. MacKillop J, Few LR, Murphy JG, Wier LM, Acker J, Murphy C, Stojek M, Carrigan M, Chaloupka F (2012) High-resolution behavioral economic analysis of cigarette demand to inform tax policy. Addiction 107:2191-2200
26. Mackinnon DP, Fairchild AJ (2009) Current directions in mediation analysis. Curr Dir Psychol Sci 18:16
27. Morley KI, Medland SE, Ferreira MA, Lynskey MT, Montgomery GW, Heath AC, Madden PA, Martin NG (2006) A possible smoking susceptibility locus on chromosome 11p12: evidence from sex-limitation linkage analyses in a sample of Australian twin families. Behavior Genet 36:87-99
28. Mota NR, Araujo-Jnr EV, Paixao-Cortes VR, Bortolini MC, Bau CH (2012) Linking dopamine neurotransmission and neurogenesis: the evolutionary history of the NTAD (NCAM1-TTC12-ANKK1-DRD2) gene cluster. Genet Mol Biol 35:912-918
29. Munafò M, Clark T, Johnstone E, Murphy M, Walton R (2004) The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 6:583-597
30. Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540-545
31. Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D, Yuan Q, Goldman D (2009) OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res 33:383-393
32. Pajewski NM, Parker SD, Poland GA, Ovsyannikova IG, Song W, Zhang K, McKinney BA, Pankratz VS, Edberg JC, Kimberly RP, Jacobson RM, Tang J, Kaslow RA (2011) The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun 12:457-465
33. Pergadia ML, Heath AC, Martin NG, Madden PA (2006) Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med 36:963-972
34. Piasecki TM, Piper ME, Baker TB (2010) Refining the tobacco dependence phenotype using the Wisconsin inventory of smoking dependence motives: II. Evidence from a laboratory self-administration assay. J Abnorm Psychol 119:513-523
35. Piper ME, Piasecki TM, Federman EB, Bolt DM, Smith SS, Fiore MC, Baker TB (2004) A multiple motives approach to tobacco dependence: the Wisconsin inventory of smoking dependence motives (WISDM-68). J Consult Clin Psychol 72:139-154
36. Piper ME, Bolt DM, Kim SY, Japuntich SJ, Smith SS, Niederdeppe J, Cannon DS, Baker TB (2008) Refining the tobacco dependence phenotype using the Wisconsin inventory of smoking dependence motives. J Abnorm Psychol 117:747-761
37. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, Hietala J (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256-260
38. Preacher KJ, Hayes AF (2008) Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40:879-891
39. Purcell S (http://pngu.mgh.harvard.edu/purcell/plink/) PLINK v1.07
40. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
41. Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD, Chen TT, Cinciripini PM (2007) The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogen J 7:266-274
42. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, Martin NG, Montgomery GW, Wang JC, Ballinger DG, Rice JP, Bierut LJ (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16:36-49
43. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169
44. Stephens M, Scheet P (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76:449-462
45. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
46. Tabachnick BG, Fidell LS (2001) Using multivariate statistics, 4th edn. Allyn &Bacon, Boston
47. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, Borrelli E (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408:199-203
48. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(1):3-8